Bendamustine vs. fludarabine/cyclophosphamide lymphodepletion prior to BCMA CAR-T cell therapy in multiple myeloma
Surbhi Sidana(Stanford Blood Center), Hitomi Hosoya(Stanford University), Alexandria Jensen(Stanford University), Lawrence Liu(City of Hope), Anmol Goyal(Stanford University), Vanna Hovanky(Stanford University), Bita Sahaf(Stanford University), Sushma Bharadwaj(Stanford University), Theresa Latchford(Stanford University), Sally Arai(Stanford University), Sheryl Leahy(City of Hope), Matthew Mei(City of Hope), Lihua E. Budde(City of Hope), Lori Muffly(Stanford University), Matthew J. Frank(Stanford University), Saurabh Dahiya(Stanford University), Myo Htut(City of Hope), David B. Miklos(Stanford University), Murali Janakiram(City of Hope)
Cited by 38Open Access
Abstract
Bendamustine vs. fludarabine
Related Papers
No related papers found
Powered by citation graph analysis